IN2014MN02418A - - Google Patents

Download PDF

Info

Publication number
IN2014MN02418A
IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
Authority
IN
India
Prior art keywords
methods
breast cancer
subject
gene expression
evaluating
Prior art date
Application number
Other languages
English (en)
Inventor
Sean M Ferree
James Justin Storhoff
Joel S Parker
Charles M Perou
Matthew J Ellis
Philip S Bernard
Torsten O Nielsen
Original Assignee
Nanostring Technologies Inc
Univ North Carolina
Univ Utah Res Found
British Columbia Cancer Agency
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanostring Technologies Inc, Univ North Carolina, Univ Utah Res Found, British Columbia Cancer Agency, Univ Washington filed Critical Nanostring Technologies Inc
Publication of IN2014MN02418A publication Critical patent/IN2014MN02418A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN2418MUN2014 2012-05-22 2013-05-22 IN2014MN02418A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261650209P 2012-05-22 2012-05-22
US201361753673P 2013-01-17 2013-01-17
PCT/US2013/042157 WO2013177245A2 (fr) 2012-05-22 2013-05-22 Gènes nano-46 et procédés de prédiction de l'évolution du cancer du sein

Publications (1)

Publication Number Publication Date
IN2014MN02418A true IN2014MN02418A (fr) 2015-08-14

Family

ID=49624503

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2418MUN2014 IN2014MN02418A (fr) 2012-05-22 2013-05-22

Country Status (12)

Country Link
US (3) US20130337444A1 (fr)
EP (1) EP2852689B1 (fr)
JP (1) JP6325530B2 (fr)
CN (2) CN104704128A (fr)
AU (1) AU2013266419B2 (fr)
BR (1) BR112014029300A2 (fr)
CA (1) CA2874492C (fr)
ES (1) ES2763931T3 (fr)
IL (1) IL235795B (fr)
IN (1) IN2014MN02418A (fr)
MX (1) MX369628B (fr)
WO (1) WO2013177245A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2297359T1 (sl) 2008-05-30 2014-05-30 The University Of North Carolina At Chapel Hill Profili genskega izraĹľanja za napovedovanje izida raka dojke
WO2012125828A2 (fr) 2011-03-15 2012-09-20 The University Of North Carolina At Chapell Hill Méthodes de traitement du cancer du sein par une thérapie par anthracycline
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US9181588B2 (en) 2011-11-30 2015-11-10 The University Of Utah Research Foundation Methods of treating breast cancer with taxane therapy
WO2014186349A1 (fr) * 2013-05-13 2014-11-20 Nanostring Technologies, Inc. Procédés de prédiction du risque de récurrence de cancer du sein de stade précoce à ganglions positifs
LT3013983T (lt) 2013-06-25 2023-05-10 Prognosys Biosciences, Inc. Erdviniai koduoti biologiniai tyrimai, naudojant mikrofluidinį įrenginį
JP2016537010A (ja) * 2013-09-09 2016-12-01 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット
EP3221469B1 (fr) 2014-11-21 2020-01-15 Nanostring Technologies, Inc Séquençage sans enzyme ni amplification
WO2016085841A1 (fr) * 2014-11-24 2016-06-02 Nanostring Technologies, Inc. Procédés et appareils pour la purification et l'imagerie de gènes
WO2016091880A1 (fr) * 2014-12-09 2016-06-16 King's College London Traitement du cancer du sein avec une thérapie au taxane
CN113186256A (zh) 2015-04-10 2021-07-30 空间转录公司 生物样本的空间区别、多重核酸分析
CN107850599B (zh) * 2015-07-23 2021-02-09 新加坡国立大学 Wbp2与her2作为共预后因子对患者分层以进行治疗
CN109715825B (zh) 2016-05-16 2023-01-06 纳米线科技公司 用于检测样品中目标核酸的方法
US11352667B2 (en) 2016-06-21 2022-06-07 10X Genomics, Inc. Nucleic acid sequencing
WO2018074865A2 (fr) * 2016-10-21 2018-04-26 서울대학교병원 Composition et procédé pour la prédiction de pronostic du cancer du sein
CA3043489A1 (fr) 2016-11-21 2018-05-24 Nanostring Technologies, Inc. Compositions chimiques et methodes d'utilisation de celles-ci
KR101950717B1 (ko) * 2016-11-23 2019-02-21 주식회사 젠큐릭스 유방암 환자의 화학치료 유용성 예측 방법
WO2018144782A1 (fr) * 2017-02-01 2018-08-09 The Translational Genomics Research Institute Procédés de détection de variants somatiques et de lignée germinale dans des tumeurs impures
CA3078158A1 (fr) 2017-10-06 2019-04-11 Cartana Ab Ligature a matrice d'arn
KR102071491B1 (ko) * 2017-11-10 2020-01-30 주식회사 디시젠 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템
JP2021523723A (ja) 2018-05-14 2021-09-09 ナノストリング テクノロジーズ，インコーポレイティド 化学的組成物とそれを利用する方法
EP3877549A1 (fr) * 2018-11-05 2021-09-15 BioNTech Diagnostics GmbH Procédés prédictifs utilisés dans le cancer du sein
CA3139791A1 (fr) 2019-05-31 2020-12-03 10X Genomics, Inc. Procede de detection de molecules d'acide nucleique cible
JP7352937B2 (ja) * 2019-07-19 2023-09-29 公立大学法人福島県立医科大学 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット
EP3945136A1 (fr) * 2020-07-28 2022-02-02 Hospital Clínic de Barcelona Procédé in vitro pour le pronostic de patients souffrant d'un cancer du sein her2-positif
WO2023117807A1 (fr) * 2021-12-20 2023-06-29 Reveal Genomics S.L Développement et validation d'un procédé in vitro pour le pronostic de patients souffrant d'un cancer du sein her2-positif

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
ES2097925T3 (es) 1991-09-18 1997-04-16 Affymax Tech Nv Metodo para sintetizar diversas colecciones de oligomeros.
EP0972564B1 (fr) 1991-11-22 2003-05-28 Affymetrix, Inc. (a Delaware Corporation) Procédé de préparation des matrices de polymères
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
EP0880598A4 (fr) 1996-01-23 2005-02-23 Affymetrix Inc Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
JP2001521753A (ja) 1997-10-31 2001-11-13 アフィメトリックス インコーポレイテッド 成人臓器及び胎児臓器中の発現プロフィール
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US6750015B2 (en) * 2000-06-28 2004-06-15 Kathryn B. Horwitz Progesterone receptor-regulated gene expression and methods related thereto
US20020168639A1 (en) * 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
ES2690168T3 (es) * 2003-06-24 2018-11-19 Genomic Health, Inc. Predicción de la probabilidad de recidiva de cáncer
EP2469439A2 (fr) * 2003-09-29 2012-06-27 Pathwork Diagnostics, Inc. Systèmes et procédés pour détecter des caractéristiques biologiques
WO2006010150A2 (fr) 2004-07-15 2006-01-26 University Of Utah Research Foundation Gènes domestiques et méthodes d'identification desdits gènes
CN101061480A (zh) * 2004-09-22 2007-10-24 三路影像公司 用来分析和优化用于癌症诊断的标记候选物的方法和计算机程序产品
EP1954708A4 (fr) 2005-11-23 2009-05-13 Univ Utah Res Found Methodes et compositions dans lesquelles sont utilises des genes intrinseques
ES2402939T3 (es) 2005-12-23 2013-05-10 Nanostring Technologies, Inc. Composiciones que comprenden macromoléculas inmovilizadas y orientadas y métodos para su preparación
CA2640385C (fr) 2005-12-23 2014-07-15 Nanostring Technologies, Inc. Nanorapporteurs et procedes de production et d'utilisation de ceux-ci
WO2008124847A2 (fr) 2007-04-10 2008-10-16 Nanostring Technologies, Inc. Procédés et systèmes informatiques pour identifier des séquences spécifiques d'une cible afin de les utiliser dans des nanoreporteurs
WO2008150512A2 (fr) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Procédés pour identifier une plus grande probabilité de récidive du cancer du sein
JP2010538609A (ja) * 2007-09-06 2010-12-16 バイオセラノスティクス，インコーポレイティド 腫瘍グレード分類と癌の予後診断
SI2297359T1 (sl) * 2008-05-30 2014-05-30 The University Of North Carolina At Chapel Hill Profili genskega izraĹľanja za napovedovanje izida raka dojke
AU2009281836B2 (en) 2008-08-14 2015-02-19 Nanostring Technologies, Inc. Stable nanoreporters
PT2845911T (pt) * 2010-03-31 2016-08-25 Sividon Diagnostics Gmbh Método para previsão da recorrência de cancro da mama em tratamento endócrino

Also Published As

Publication number Publication date
EP2852689A4 (fr) 2016-05-11
IL235795A0 (en) 2015-01-29
JP2015518724A (ja) 2015-07-06
US20230272476A1 (en) 2023-08-31
WO2013177245A3 (fr) 2015-01-29
AU2013266419A1 (en) 2014-12-11
CN111500718A (zh) 2020-08-07
EP2852689A2 (fr) 2015-04-01
US20130337444A1 (en) 2013-12-19
WO2013177245A2 (fr) 2013-11-28
US20200332368A1 (en) 2020-10-22
AU2013266419B2 (en) 2018-09-27
EP2852689B1 (fr) 2019-12-11
BR112014029300A2 (pt) 2017-07-25
MX2014014275A (es) 2015-07-06
JP6325530B2 (ja) 2018-05-16
IL235795B (en) 2020-02-27
ES2763931T3 (es) 2020-06-01
CA2874492A1 (fr) 2013-11-28
CN104704128A (zh) 2015-06-10
CA2874492C (fr) 2021-10-19
MX369628B (es) 2019-11-14

Similar Documents

Publication Publication Date Title
IN2014MN02418A (fr)
CY1114993T1 (el) Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου
MX2019007814A (es) Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata.
MX2015011362A (es) Metodo para el pronostico y tratamiento de metastasis de cancer.
EP4219765A3 (fr) Pronostic du cancer de la prostate à l'aide de biomarqueurs
NZ599194A (en) Methods to predict clinical outcome of cancer
WO2013006443A3 (fr) Découverte d'une mutation somatique dans le gène myd88 du lymphome lymphoblasmocytaire
WO2010051314A3 (fr) Classification génomique de carcinomes pulmonaires non à petites cellules en fonction de profils d'altérations du nombre de copies de gènes
MX362041B (es) Método para el pronóstico y tratamiento de cáncer metastásico de los huesos originado de cáncer de mama.
PH12014502410A1 (en) Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression
WO2011153545A3 (fr) Signature d'expression génique utilisée pour prédire une réponse à une chimiothérapie lors d'un cancer du sein
NZ621638A (en) Dna methylation in colorectal and breast cancer diagnostic methods
WO2014184679A3 (fr) Procédé de pronostic et de traitement de la métastase d'un carcinome des cellules rénales
MX2013008252A (es) Firma de pronostico para la recurrencia de cancer colorrectal.
BR112015022977A2 (pt) métodos para predição de risco de metástase em melanoma cutâneo
MX2016012718A (es) Determinación de polimorfismos de un solo nucleótido útil para predecir la respuesta para rasagilina.
RU2010149541A (ru) Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением
MX2013013153A (es) La expresion de kiaa1456 predice la supervivencia en pacientes con cancer de colon.
Eapen Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
WO2013010140A3 (fr) Procédés de diagnostic du cancer
MX2017004816A (es) Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
RU2012140862A (ru) Способ прогнозирования риска возникновения переломов
RU2011134465A (ru) Метод оценки предрасположенности человека к онкологическим заболеваниям на основе значимых полиморфизмов единичных нуклеотидов
WO2011133500A3 (fr) Détection et analyse des changements épigénétiques et génétiques dans le tissu tumoral
UA95616U (uk) Спосіб прогнозування зрощення перелому